Prescription Drug Information: Venlafaxine Hydrochloride (Page 11 of 11)
Package/Label Display Panel
NDC: 42708-054-30
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride capsule, extended release | ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
|
Labeler — QPharma Inc (030620888) |
Registrant — Teva Pharmaceuticals USA, Inc. (001627975) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Northwind Pharmaceuticals, LLC | 036986393 | repack (42708-054) |
Revised: 01/2023 QPharma Inc
RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.
https://rxdruglabels.com/lib/rx/rx-meds/venlafaxine-hydrochloride-59/page/11/